Get the latest GNBT - Generex Biotechnology Corporation stock market performance data and financial news.
Get the latest GNBT - Generex Biotechnology Corporation together with stock market performance data and financial news.
Read Jim Cramer's take on Generex Biotechnology Corporation (GNBT) and get his latest thoughts on the company?s performance and outlook
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
A large order from the Middle East boosted the company's revenue, but selling expenses and other factors added to the company's net loss.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10471371/1/generex-posts-net-loss-in-second-quarter.html
Despite surging third quarter revenue, the drug company's net loss increased to $0.08 per share.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10511995/1/generexs-net-loss-widens-on-interest-expense.html
ImClone is falling.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10362122/1/tuesdays-health-winners-losers.html
Continucare is declining.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10309574/1/mondays-small-cap-winners-losers.html
Nektar and MannKind tumble on inhaled insulin drug data.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10411390/1/wednesdays-health-winners-losers.html
This last-ditch financing tool continues to find takers.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10284937/1/death-spiral-convertible-just-refuses-to-die.html
Connect with TheStreet